BAP1 and nonpapillary renal cell carcinoma: Kaplan-Meier analysis revealed that patients with a BAP1 mutation exhibited poorer overall survival (OS) compared to those with wild-type BAP1 (Figure 9C), suggesting that BAP1 mutation may serve as an independent prognostic factor for predicting the outcome of ccRCC patients.